Bioinfra is a Contract Research Organization (CRO) that provides bioanalytical services including method development/validation/transfer and measurement of drug concentrations in plasma, serum, urine, and tissues collected in clinical studies (phase I and bioequivalence) and preclinical studies (toxicology and screening pharmacokinetic).
Benefits include higher productivity (60% faster than major CRO’s) and 50% lower cost on bioanalysis.
Ideal projects include bioanalytical method development/validation/transfer by using LC-UV/FLD or LC-MS/MS and bioanalysis of samples collected in clinical and preclinical studies.
Work is performed in Suwon, South Korea.
BioInfra is seeking partners in North America and Europe. Ideal partners include other Contract Research Organizations (CRO) and pharmaceutical companies. For more information, please contact Adam Bates at email@example.com or at 512-305-0986.
Tagged: Gyeonggi, Life Science, South Korea